Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
AstraZeneca’s H1 2022 Revenues Surge 48%, Led by Oncology and Vaccines
February 17, 2025
Company
Drug
Lee’s Pharma Completes Enrollment for NVK-002 Myopia Trials in China
February 17, 2025
Company
Drug
Lynk Pharma Gets NMPA Green Light for LNK01004 Atopic Dermatitis Study
February 17, 2025
Company
Drug
Sciwind Biosciences’ XW003 Hits Phase II Trial Goals in Type 2 Diabetes Treatment
February 17, 2025
Company
Deals
Fosun Pharma’s Proxima AI Raises Over RMB 100M in Strategic Financing
February 17, 2025
Company
Deals
Taibang Biologic Raises $300M in Post-Privatization Financing Round
February 17, 2025
Company
Deals
Sironax Completes $200 Million Series B Financing for Age-Related Disease Therapies
February 17, 2025
Company
Deals
ImmVira Partners with China Resources Biopharmaceutical on Oncolytic Virus MVR-C5252 for Gliomas
June 26, 2025
Company
Deals
Tus-Pharma to Acquire Sinotau Pharma for RMB 220 Million
February 17, 2025
Company
Drug
Eli Lilly Files for Baqsimi Approval in China to Treat Severe Hypoglycemia
February 17, 2025
Company
Drug
Aosaikang’s ASKG315 Receives Ethics Approval for Phase I Cancer Trial in Australia
February 17, 2025
Company
Ablaze Pharma to Invest $100M in Chengdu TRT R&D and Manufacturing Hub
February 17, 2025
1
2
…
1,159
1,160
1,161
1,162
1,163
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?